Tekturna Can Cause Renal Failure, Kidney Complications and Strokes
Tekturna (Aliskiren) belongs to a class of drugs known as rennin inhibitors, and is used primarily for the treatment of hypertension. But Tekturna has been wrought with controversy almost since the moment it hit the market, with evidence of patients suffering stroke, renal complications, hypotension, hyperkalemia and more. And new evidence only adds to the concerns about devastating Tekturna side effects.
Tekturna was approved by the Food and Drug Administration back in March of 2007, after it was evaluated for safety in 6,460 patients. Of those patients, only 1,250 were treated for longer than 1 year, but as we have seen time and time again, the true potential for adverse effects often does not reveal itself until thousands of millions of exposures occur in a wide population. This may have something to do with why the FDA uncovered no red flags with Tekturna.
But in December of 2011, the drug company Novartis announced that it was ending its clinical ALTITUDE study of Tekturna, after researchers noticed an elevated number of serious adverse side effects in the study’s participants. Since that time, the FDA has issued new warnings about Tekturna and other antihypertensive drugs containing aliskiren.
According to an April 2012 article in Forbes, “The FDA now states that these drug combinations are contraindicated in patients with diabetes, and it is new warning to avoid the use of this combination in patients with moderate to severe renal impairment (GFR <60 mL/min).”
Additionally, a well-known consumer advocacy group called Public Citizen is requesting a “Black-Box Warning” for Tekturna and certain similar medications, so that doctors are alerted to avoid using the drugs, particularly with one another. The group’s “Petition to the FDA for Black Box Warnings on ACE Inhibitors, ARBs, and Aliskiren” notes that “The drugs, given individually, are effective in treating high blood pressure, but when used in combination, cause life-threatening side effects with no added benefit.”
Have you or someone you love taken Tekturna or a similar drug for high blood pressure or hypertension, and subsequently experienced renal kidney failure, stroke, hypotension or other similar problems? If so, you may be entitled to compensation. We have been aggressively pursuing Tekturna cases in California and throughout the nation, and we have recovered millions for our clients.
Get in touch with an aggressive Tekturna attorney at Nadrich & Cohen LLP, by calling us at 1-800-718-4658. Your case evaluation is always free and completely confidential, and we’ll let you know immediately whether you have a case. As contingency lawyers, we only accept payment if we win you a recovery, so don’t be held back by an inability to pay for legal services. Give us a call today.